1. Home
  2. EVAX vs OP Comparison

EVAX vs OP Comparison

Compare EVAX & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • OP
  • Stock Information
  • Founded
  • EVAX 2008
  • OP 2021
  • Country
  • EVAX Denmark
  • OP Greece
  • Employees
  • EVAX N/A
  • OP N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • OP
  • Sector
  • EVAX Health Care
  • OP
  • Exchange
  • EVAX Nasdaq
  • OP Nasdaq
  • Market Cap
  • EVAX 8.7M
  • OP 8.5M
  • IPO Year
  • EVAX 2021
  • OP N/A
  • Fundamental
  • Price
  • EVAX $2.62
  • OP $1.12
  • Analyst Decision
  • EVAX Strong Buy
  • OP
  • Analyst Count
  • EVAX 3
  • OP 0
  • Target Price
  • EVAX $33.33
  • OP N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • OP 12.1K
  • Earning Date
  • EVAX 03-26-2025
  • OP 12-20-2024
  • Dividend Yield
  • EVAX N/A
  • OP N/A
  • EPS Growth
  • EVAX N/A
  • OP N/A
  • EPS
  • EVAX N/A
  • OP N/A
  • Revenue
  • EVAX $3,295,000.00
  • OP $25,729,000.00
  • Revenue This Year
  • EVAX $4,845.21
  • OP N/A
  • Revenue Next Year
  • EVAX $30.30
  • OP N/A
  • P/E Ratio
  • EVAX N/A
  • OP N/A
  • Revenue Growth
  • EVAX N/A
  • OP 36.33
  • 52 Week Low
  • EVAX $2.22
  • OP $1.02
  • 52 Week High
  • EVAX $23.70
  • OP $3.15
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • OP 40.22
  • Support Level
  • EVAX $2.22
  • OP $1.11
  • Resistance Level
  • EVAX $4.05
  • OP $1.24
  • Average True Range (ATR)
  • EVAX 1.17
  • OP 0.05
  • MACD
  • EVAX 0.00
  • OP -0.00
  • Stochastic Oscillator
  • EVAX 6.99
  • OP 7.17

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

Share on Social Networks: